Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Mimran

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Hypertension|December 7, 2014
Arterial stiffness, pulse pressure, and the kidneyMichel E Safar, Gérard E Plante, Albert Mimran
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 10, 2006
Prevention and reversal by enalapril of target organ damage in angiotensin II hypertensionCaroline Rugale, Magali Cordaillat, Albert Mimran, et al.
Journal of Cardiovascular Pharmacology|September 20, 2007
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazineCaroline Rugale, Sandrine Delbosc, Albert Mimran, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Time-course reduction of renal function in rats on high sodium intake: acute reversal by potassium canrenoateCaroline Rugale, Magali Cordaillat, Albert Mimran, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2010
Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin systemGuilhem du Cailar, Pierre Fesler, Jean Ribstein, et al.
Journal of Hypertension|August 20, 2010
Glomerular hemodynamics and arterial function in normal individualsPierre Fesler, Guilhem du Cailar, Jean Ribstein, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2004
Heterogeneity of cardiorenal characteristics in normotensive subjectsPierre Fesler, Guilhem du Cailar, Jean Ribstein, et al.
Kidney International|April 21, 2005
Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjectsPierre Fesler, Jean Ribstein, Guilhem du Cailar, et al.
Diabetes Care|February 15, 2008
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2003
Left ventricular remodeling and renal function in never-treated essential hypertensionPierre Fesler, Guilhem Du Cailar, Jean Ribstein, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Hypertension|December 7, 2014
Arterial stiffness, pulse pressure, and the kidneyMichel E Safar, Gérard E Plante, Albert Mimran
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 10, 2006
Prevention and reversal by enalapril of target organ damage in angiotensin II hypertensionCaroline Rugale, Magali Cordaillat, Albert Mimran, et al.
Journal of Cardiovascular Pharmacology|September 20, 2007
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazineCaroline Rugale, Sandrine Delbosc, Albert Mimran, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Time-course reduction of renal function in rats on high sodium intake: acute reversal by potassium canrenoateCaroline Rugale, Magali Cordaillat, Albert Mimran, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2010
Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin systemGuilhem du Cailar, Pierre Fesler, Jean Ribstein, et al.
Journal of Hypertension|August 20, 2010
Glomerular hemodynamics and arterial function in normal individualsPierre Fesler, Guilhem du Cailar, Jean Ribstein, et al.
Hypertension (Dallas, Tex. : 1979)|January 14, 2004
Heterogeneity of cardiorenal characteristics in normotensive subjectsPierre Fesler, Guilhem du Cailar, Jean Ribstein, et al.
Kidney International|April 21, 2005
Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjectsPierre Fesler, Jean Ribstein, Guilhem du Cailar, et al.
Diabetes Care|February 15, 2008
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2003
Left ventricular remodeling and renal function in never-treated essential hypertensionPierre Fesler, Guilhem Du Cailar, Jean Ribstein, et al.
Pageof 5